Search research articles
Contact Us
Filters
Showing results (301-310 of 350) with videos related to
Page
of 35
Sort By:
Hepatology (Baltimore, Md.)
|
December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem, Ahmed Gabr, Ahsun Riaz, et al.
JAMA
|
June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Alan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Archives of Internal Medicine
|
May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
Charles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 19, 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer
Donald A Podoloff, Ranjana H Advani, Craig Allred, et al.
Cancer Research
|
February 12, 2005
Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT
Garry P Larson, Yan Ding, Li S-C Cheng, et al.
Gastroenterology
|
November 4, 2010
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma
Riad Salem, Robert J Lewandowski, Laura Kulik, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 30, 2010
Pancreatic adenocarcinoma
Margaret A Tempero, J Pablo Arnoletti, Stephen Behrman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 14, 2015
Neuroendocrine tumors, version 1.2015
Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 17, 2009
NCCN Clinical Practice Guidelines in Oncology: colon cancer
Paul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 350) with videos related to
Sort By:
Page
of 35
Hepatology (Baltimore, Md.)
|
December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem, Ahmed Gabr, Ahsun Riaz, et al.
JAMA
|
June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Alan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Archives of Internal Medicine
|
May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
Charles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 19, 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer
Donald A Podoloff, Ranjana H Advani, Craig Allred, et al.
Cancer Research
|
February 12, 2005
Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT
Garry P Larson, Yan Ding, Li S-C Cheng, et al.
Gastroenterology
|
November 4, 2010
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma
Riad Salem, Robert J Lewandowski, Laura Kulik, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 30, 2010
Pancreatic adenocarcinoma
Margaret A Tempero, J Pablo Arnoletti, Stephen Behrman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 14, 2015
Neuroendocrine tumors, version 1.2015
Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 17, 2009
NCCN Clinical Practice Guidelines in Oncology: colon cancer
Paul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Page
of 35